InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
2
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by FLESHER GREGORY J., Chairman & CEO. Officer active across 1 company, notably Reneo Pharmaceuticals, Inc.. Cumulatively, 4 disclosures have been recorded. Split: 2 buys · 0 sell. Total volume traded: €109k. Activity tracked since 25 August 2021. The latest transaction was filed on 10 December 2021 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations4 total
100,000 shares0Common StockSEC:0001209191-21-069443:0
100,000 shares0Common StockSEC:0001209191-21-069443
8,000 shares@ US$8.0050.0% of flowCommon StockSEC:0001209191-21-053522:0
Ideal exit: 22 May 2022 (T+270)
8,000 shares@ US$8.0050.0% of flowCommon StockSEC:0001209191-21-053522
Ideal exit: 22 May 2022 (T+270)
4 of 4 declarations
About FLESHER GREGORY J.
Flesher Gregory J. is the President and CEO of Reneo Pharmaceuticals, Inc. He leads the company with a focus on developing innovative treatments for metabolic diseases. His leadership and strategic vision are essential in guiding Reneo's research and development efforts aimed at improving patients' quality of life.
